Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on Sunshine Biopharma Inc's Total Debt / EBITDA:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Total Debt / EBITDA in the risk category include:
A ratio that is calculated as Total Debt (including Capital Leases) divided by EBITDA.
Total Debt / EBITDA ratio measures leverage in terms of total debt while using EBITDA as a proxy for cash flow.
Short Term Borrowings
(+) Current Portion of Long Term Debt
(+) Current Portion of Lease Liabilities
(+) Long Term Debt
(+) Long Term Lease Liabilities
(=) Total Debt
EBITDA is Earnings before Interest, Taxes, Depreciation & Amortization